RUBICON RESEARCH (RUBICON) Share Price Falls for Second Straight Session

RUBICON RESEARCH Share Price is lower in its second straight session, with the latest traded price at Rs 1,540 and a cumulative decline of 3.59% across the run from Rs 1,597.30. Univest figures confirm the price action, but they do not point to a specific company trigger. RUBICON RESEARCH Share Price therefore remains a clear streak watch rather than a one-line move story.

RUBICON RESEARCH Share Price also matters because the company carries a market capitalisation of Rs 26,440.41 crore and sits in the Large Cap category. For a reader, two consecutive lower sessions mean the current move is more than a single-day swing: it shows continuation across sessions, even though the data itself does not assign a reason. RUBICON RESEARCH Share Price Fall Streak is the right lens for interpreting the numbers that follow.

RUBICON RESEARCH (RUBICON) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 1,540
Previous Close	Rs 1,574.9
Today's Move	-Rs 34.90 (-2.22%)
Open	Rs 1,567.15
High	Rs 1,580.05
Low	Rs 1,540
Market Capitalisation	Rs 26,440.41 crore

RUBICON RESEARCH Share Price opened at Rs 1,567.15, touched a high of Rs 1,580.05 and a low of Rs 1,540, before last trading at Rs 1,540. Against the previous close of Rs 1,574.90, the stock was down Rs 34.90, or 2.22%, in the latest leg of the RUBICON RESEARCH Share Price Fall Streak. The day’s range shows the latest traded price sat at the lowest point provided for the session, which keeps the focus squarely on the weaker intraday tone. Market capitalisation stood at Rs 26,440.41 crore, and the Large Cap label is relevant context for size. RUBICON RESEARCH Share Price has now moved lower for a second straight session, and that sequence is more meaningful than a standalone slip because it extends the price event across trading days. RUBICON RESEARCH Share Price Fall Streak therefore needs to be read as a continuing price pattern, not an isolated print. The next lens is whether valuation and operating metrics still support the same market profile.

What the Consecutive Declines Show

The RUBICON RESEARCH Share Price Fall Streak shows a two-session move from Rs 1,597.30 to Rs 1,540, which translates into a cumulative decline of 3.59%. That is the most useful way to read this event: the stock did not just weaken once, it extended the decline into a second straight session. RUBICON RESEARCH Share Price also moved inside a relatively tight range on the latest session, with the low matching the final traded level. In streak terms, that keeps the emphasis on persistence rather than speed. For RUBICON RESEARCH Share Price, the streak framing matters because it separates a continuation pattern from a one-off session. The latest move is confirmed by the numbers, while the reason remains unestablished in the verified data. RUBICON RESEARCH Share Price Fall Streak is therefore best interpreted as a measured but continued downside pattern.

RUBICON RESEARCH (RUBICON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 26,440.41 crore
P/E Ratio	90.45x
P/B Ratio	19.42x
ROE	27.84%
ROCE	29.22%
EPS	Rs 17.41
Book Value Per Share	Rs 81.09
Dividend Yield	0.1%

RUBICON RESEARCH (RUBICON) fundamental metrics show P/E 90.45x, P/B 19.42x, ROE 27.84%, ROCE 29.22%. Taken on their own, these numbers offer context rather than a trading signal.

RUBICON RESEARCH has a market capitalisation of Rs 26,440.41 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 90.45x, P/B at 19.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	90.45x
Benchmark Median P/E	31.87x
Benchmark Average P/E	48.48x
Benchmark P/E Range	3.58x to 708.87x
Company P/B Ratio	19.42x
Benchmark Median P/B	2.98x
Benchmark Average P/B	4.31x
Company ROE	27.84%
Benchmark Median ROE	11.61%
Benchmark Average ROE	10.59%
Company ROCE	29.22%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.36%
Company Market Capitalisation	Rs 26,440.41 crore
Benchmark Median Market Cap	Rs 854.81 crore
Benchmark Average Market Cap	Rs 14,121.7 crore

RUBICON RESEARCH (RUBICON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

RUBICON RESEARCH (RUBICON) has a P/E ratio of 90.45x, which is above the benchmark median of 31.87x, a difference of +183.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

RUBICON RESEARCH (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.61%, a difference of +139.79%. RUBICON RESEARCH (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.46%, a difference of +117.09%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,32,120.23	35.37	4.95	14.85	19.11
Divi's Laboratories	DIVISLAB	2,53,389.76	86.95	14.4	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,81,739.76	82.14	19.96	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,15,710.44	25.51	4.27	19.69	21.39
Laurus Labs	LAURUSLABS	1,10,980.13	101.55	19.69	18.31	18.2

RUBICON RESEARCH (RUBICON) has a P/E ratio of 90.45x compared with the displayed peer median of 82.14x. The comparison is relative and should not be read as a recommendation. Its ROE of 27.84% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH (RUBICON) has a market capitalisation of Rs 26,440.41 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching RUBICON RESEARCH

• RUBICON RESEARCH Share Price is in a second straight session of decline, so the streak itself is the first point to monitor.
• The latest traded price of Rs 1,540 sits below the previous close of Rs 1,574.90, keeping RUBICON RESEARCH Share Price under immediate attention.
• RUBICON RESEARCH Share Price still reflects a P/E of 90.45 and a P/B of 19.42, which remain high versus sector norms.
• ROE of 27.84% and ROCE of 29.22% show that RUBICON RESEARCH Share Price is backed by strong return metrics.
• RUBICON RESEARCH Share Price remains a Large Cap with Rs 26,440.41 crore market capitalisation, so the move matters in a sizeable company.

About RUBICON RESEARCH

RUBICON RESEARCH operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For reading the RUBICON RESEARCH Share Price Fall Streak, the useful business context is simply that it is a large listed pharma company with a market capitalisation of Rs 26,440.41 crore. The valuation and return profile suggest the market assigns it a premium status within the industry. That matters because RUBICON RESEARCH Share Price is not moving from a low base; it is moving from an elevated valuation zone. For investors tracking RUBICON RESEARCH Share Price, the business lens is therefore tied to sector standing, return ratios and the premium multiples already visible in the numbers.

Track RUBICON RESEARCH Share Price on Univest

Use RUBICON RESEARCH (RUBICON) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track RUBICON RESEARCH Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. RUBICON RESEARCH Share Price pages also help readers compare valuation and return metrics with sector and peer benchmarks. For a streak event like this, RUBICON RESEARCH Share Price Fall Streak can be followed alongside the same-company history and market context on Univest.

Frequently Asked Questions

Why is RUBICON RESEARCH Share Price falling today?

Ans. RUBICON RESEARCH Share Price is lower in a second straight session, with the latest traded price at Rs 1,540 and the day down 2.22%. Univest figures confirm the price action, but they do not point to a specific company trigger.

What does the second straight session mean for RUBICON RESEARCH Share Price?

Ans. The second straight session means RUBICON RESEARCH Share Price has declined on back-to-back trading days. The cumulative move across the streak is a 3.59% fall from Rs 1,597.30 to Rs 1,540, which is more informative than one session alone.

What was the latest traded price of RUBICON RESEARCH Share Price?

Ans. RUBICON RESEARCH Share Price last traded at Rs 1,540. That level was also the session low provided, after the stock opened at Rs 1,567.15 and touched a high of Rs 1,580.05 during the day.

How did RUBICON RESEARCH Share Price perform versus the previous close?

Ans. RUBICON RESEARCH Share Price was down Rs 34.90 from the previous close of Rs 1,574.90. The percentage change was -2.22%, which keeps the stock lower in the current streak rather than in a single isolated move.

What is the market capitalisation of RUBICON RESEARCH ?

Ans. RUBICON RESEARCH has a market capitalisation of Rs 26,440.41 crore. That places it in the Large Cap category and gives the current price fall more relevance than a small one-off move in a much smaller company.

How expensive is RUBICON RESEARCH Share Price on valuation?

Ans. RUBICON RESEARCH Share Price trades at a P/E of 90.45 and a P/B of 19.42. Both are above the Healthcare benchmark median of 31.87 and 2.98, respectively, so the stock still looks premium after the fall.

What do ROE and ROCE show for RUBICON RESEARCH Share Price?

Ans. RUBICON RESEARCH Share Price has ROE of 27.84% and ROCE of 29.22%. Both readings are above the benchmark medians in the same industry set, which gives the valuation context a stronger return backdrop.

What do EPS and book value say about RUBICON RESEARCH Share Price?

Ans. RUBICON RESEARCH Share Price has EPS of Rs 17.41 and book value of Rs 81.09. These figures help explain the valuation base behind the stock, especially when the current price is much higher than book value.

How does RUBICON RESEARCH compare with healthcare peers?

Ans. RUBICON RESEARCH Share Price carries a higher P/E than several listed healthcare peers, including Sun Pharmaceutical Industries at 35.37 and Cipla at 31.87. Its ROE and ROCE also sit near the stronger end of the group.

Where can investors track RUBICON RESEARCH Share Price next?

Ans. Investors can track RUBICON RESEARCH Share Price on Univest for live price updates, valuation ratios, 52-week levels and sector context. That helps place the current fall streak beside the company’s broader market position.